[go: up one dir, main page]

WO2024026542A1 - Method for quantification of doppler velocimetry in blood vessels - Google Patents

Method for quantification of doppler velocimetry in blood vessels Download PDF

Info

Publication number
WO2024026542A1
WO2024026542A1 PCT/BG2022/050004 BG2022050004W WO2024026542A1 WO 2024026542 A1 WO2024026542 A1 WO 2024026542A1 BG 2022050004 W BG2022050004 W BG 2022050004W WO 2024026542 A1 WO2024026542 A1 WO 2024026542A1
Authority
WO
WIPO (PCT)
Prior art keywords
doppler
blood vessels
area
modalities
measurement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/BG2022/050004
Other languages
French (fr)
Inventor
Petar Ignatov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
"dreamworks Instrument Solutions" Ltd
Original Assignee
"dreamworks Instrument Solutions" Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "dreamworks Instrument Solutions" Ltd filed Critical "dreamworks Instrument Solutions" Ltd
Priority to EP22772404.4A priority Critical patent/EP4565128A1/en
Priority to PCT/BG2022/050004 priority patent/WO2024026542A1/en
Publication of WO2024026542A1 publication Critical patent/WO2024026542A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026Measuring blood flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026Measuring blood flow
    • A61B5/0285Measuring or recording phase velocity of blood waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/06Measuring blood flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08Clinical applications
    • A61B8/0808Clinical applications for diagnosis of the brain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08Clinical applications
    • A61B8/0891Clinical applications for diagnosis of blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48Diagnostic techniques
    • A61B8/488Diagnostic techniques involving Doppler signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/52Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/5215Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves involving processing of medical diagnostic data
    • A61B8/5223Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves involving processing of medical diagnostic data for extracting a diagnostic or physiological parameter from medical diagnostic data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2503/00Evaluating a particular growth phase or type of persons or animals
    • A61B2503/02Foetus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/02108Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
    • A61B5/02116Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026Measuring blood flow
    • A61B5/0295Measuring blood flow using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography

Definitions

  • the method which is a subject of the present invention, is applicable to all areas of medicine where blood oxidation levels must be monitored and more specifically - in maternal fetal medicine.
  • Doppler velocimetry has been widely used throughout the years as a most valuable tool in the follow-up and prognosis of various pregnancy complications, such as fetal growth restriction, fetal anaemia, as well as twin-to-twin transfusion syndrome in multiple pregnancies (1).
  • middle cerebral artery pulsatility index
  • pulsatility index is a commonly used modality to assess fetal well-being, especially in late FGR.
  • the measurement of middle cerebral artery’s pulsatility index continues to serve as a gold standard for the assessment of fetal brain-sparing.
  • fetal brain Doppler assessment is currently narrowed to monitoring late fetal growth restriction (>32 weeks of gestation), where cerebroplacental ratio and middle cerebral artery Doppler may be of specific clinical value [11,12,13].
  • the so called “dicrotic notch” is a small and brief increase in arterial blood pressure that appears when the aortic valve closes.
  • This landmark has been widely referred to in the descriptive analysis of the arterial waveform (especially of aortic and radial arteries) and is commonly used as an equivalent of end-systolic left ventricular pressure [14,15,16,17],
  • the dicrotic notch is universally associated with aortic valve closure [18], and possibly with changes in the peripheral vascular resistance [19], although to date, no physical mechanism for the existence of the dicrotic notch has been demonstrated convincingly.
  • Doppler velocimetry In middle cerebral artery Doppler velocimetry, it can be used as a marker of the end of systole and beginning of diastole. Visual dicrotic notch representation, as it appears on Pulse wave Doppler, is shown on figure 3.
  • dicrotic notch serving as a readily recognizable marker to indicate the beginning of diastole, it is necessary to appoint a suitable measurement tool to quantify the brain-sparing effect.
  • the systolic area in Pulse wave waveforms is being measured, defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels (arteries or veins).
  • subject of measurement is the diastolic area in Pulse wave waveforms (or other Doppler modalities), defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels (arteries or veins).
  • Figure 1 represents the common use of the Doppler measurement of the blood velocity
  • Figure 1 Shown in the image on the left is a PI of 1.74 at 34 weeks of gestation (normal finding).
  • the DN can be used as a demarcation tool to define systole and diastole
  • the DDA shape is defined by DN - dicrotic notch, D - end diastolic velocity and At - (t2 - tl).
  • Method for evaluation of the blood flow, characterized by measurement of areas under the curve of Pulse wave waveforms (or other Doppler modalities) of blood vessels (arteries or veins).
  • the systolic area in Pulse wave waveforms is being measured, defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels (arteries or veins).
  • subject of measurement is the sdiastolic area in Pulse wave waveforms (or other Doppler modalities), defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels (arteries or veins).
  • the diastolic deceleration area can be quantified with the following trapezoid area formula:
  • A V2 (a + b) h
  • A area
  • a ” and “b ” are the bases of the trapezoid
  • h is height.
  • Doppler curve quantification provides means for earlier diagnosis of fetal hypoxemia/hypoxia and anaemia, growth restriction, as well as broader spectrum of diagnostic possibilities in twin-to-twin transfusion syndrome and other conditions;
  • Pulse wave Doppler calculation of systolic and diastolic areas in Pulse wave Doppler is applicable in all areas of human and veterinary medicine.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

For more correct measurement of the blood velocity it is proposed a method for evaluation of the blood flow, including step of measurement the curve of wave waveforms (or other Doppler modalities), derived from Doppler velocimetry of blood vessels (arteries or veins), characterized in measurement of areas under the said curve of Pulse wave waveforms (or other Doppler modalities). The area is a systolic area in Pulse wave waveforms (or other Doppler modalities), defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels. The area is a diastolic area in Pulse wave waveforms (or other Doppler modalities), defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels.

Description

Method for quantification of Doppler velocimetry in blood vessels
Field of invention
The method, which is a subject of the present invention, is applicable to all areas of medicine where blood oxidation levels must be monitored and more specifically - in maternal fetal medicine.
Prior Art
Doppler velocimetry has been widely used throughout the years as a most valuable tool in the follow-up and prognosis of various pregnancy complications, such as fetal growth restriction, fetal anaemia, as well as twin-to-twin transfusion syndrome in multiple pregnancies (1).
The concept of intra-uterine growth restriction first emerged in 1960, as Battaglia and Lubchenco began to adjust newborn birth weight according to the corresponding gestational age (2).
Since then, numerous Doppler indices have been introduced to quantitatively describe fetal blood flow. Currently, the Pulsatility index seems to be the most widely used tool for that purpose. It was originally defined in 1969 by Gosling and King [3] and later simplified to today’s well-known formulation (Fig. 1)
In current clinical practice, the measurement of middle cerebral artery’s pulsatility index is a commonly used modality to assess fetal well-being, especially in late FGR. In 1986, it has been shown [5] that lower impedance to flow in the middle cerebral artery (detectable by a decrease in the pulsatility index) is uniformly associated with a redistribution of cardiac output flow towards the central nervous system, to address oxygen deficiency (brain-sparing effect). Cerebral vasodilation and thus lowered cerebral vascular resistance lead to increased end-diastolic flow velocity in the cerebral arteries [6]. Almost 40 years after the original concept introduction, the measurement of middle cerebral artery’s pulsatility index continues to serve as a gold standard for the assessment of fetal brain-sparing.
Limitations of the current clinical practice
However, a large number of authors have proposed that the calculation of cerebroplacental ratio is of additional value to diagnose brain-sparing [7, 8, 9].
Data from a recent meta-analysis underlines that this ratio between middle cerebral artery and umbilical artery pulsatility indexes, delivers higher sensitivity than middle cerebral artery alone to predict adverse perinatal and neonatal outcomes [10]. Namely, the middle cerebral artery Doppler is found to be significantly inferior to umbilical artery Doppler in predicting low Apgar score (p=0.017) and emergency delivery for fetal distress (p=0.034), and significantly inferior to cerebroplacental ratio in predicting composite adverse outcome (p<0.001) and emergency delivery for fetal distress (p=0.013).
Due to the aforementioned observations, clinical implementation of fetal brain Doppler assessment is currently narrowed to monitoring late fetal growth restriction (>32 weeks of gestation), where cerebroplacental ratio and middle cerebral artery Doppler may be of specific clinical value [11,12,13].
In a comparison between normal and abnormal middle cerebral artery Doppler waveforms (Error! Reference source not found.), it is clearly seen that most of the changes appear in the diastolic part of the heart cycle. Therefore, the pulsatility index which contains elements both from systole (peak systolic velocity - S, Error!
Reference source not found.) and from diastole (end diastolic velocity - D, Error! Reference source not found.), may not be the most effective tool to quantify brain sparing. We hypothesize that another measurement modality, which focuses predominantly on the diastole, needs to be introduced. Subject-matter of the invention
An easy to identify notching, appearing on the declining part of Doppler waveforms could be a more accurate tool for the interpretation of brain vessels vasodilatation.
The so called “dicrotic notch” is a small and brief increase in arterial blood pressure that appears when the aortic valve closes. This landmark has been widely referred to in the descriptive analysis of the arterial waveform (especially of aortic and radial arteries) and is commonly used as an equivalent of end-systolic left ventricular pressure [14,15,16,17],
The dicrotic notch is universally associated with aortic valve closure [18], and possibly with changes in the peripheral vascular resistance [19], although to date, no physical mechanism for the existence of the dicrotic notch has been demonstrated convincingly.
In middle cerebral artery Doppler velocimetry, it can be used as a marker of the end of systole and beginning of diastole. Visual dicrotic notch representation, as it appears on Pulse wave Doppler, is shown on figure 3.
With the dicrotic notch serving as a readily recognizable marker to indicate the beginning of diastole, it is necessary to appoint a suitable measurement tool to quantify the brain-sparing effect.
This can be achieved by a method (subject of the claimed invention) for evaluation of the blood flow, characterized by measurement of areas under the curve of Pulse wave waveforms (or other Doppler modalities) of blood vessels (arteries or veins).
In one embodiment of the method, the systolic area in Pulse wave waveforms (or other Doppler modalities) is being measured, defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels (arteries or veins).
In another embodiment the method, subject of measurement is the diastolic area in Pulse wave waveforms (or other Doppler modalities), defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels (arteries or veins).
Brief description of the drawings Figure 1 represents the common use of the Doppler measurement of the blood velocity;
Figure 1. Shown in the image on the left is a PI of 1.74 at 34 weeks of gestation (normal finding).
Figure 2. The DN can be used as a demarcation tool to define systole and diastole
Figure 3. the DDA shape is defined by DN - dicrotic notch, D - end diastolic velocity and At - (t2 - tl).
Embodiment of the invention
Method (subject of the claimed invention) for evaluation of the blood flow, characterized by measurement of areas under the curve of Pulse wave waveforms (or other Doppler modalities) of blood vessels (arteries or veins).
In one embodiment of the method, the systolic area in Pulse wave waveforms (or other Doppler modalities) is being measured, defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels (arteries or veins).
In another embodiment the method, subject of measurement is the sdiastolic area in Pulse wave waveforms (or other Doppler modalities), defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels (arteries or veins).
It is hypothesized that in order to calculate the amount of vasodilatation more precisely (compared to pulsatility index), the area of the highlighted trapezoid shape (which we refer to as “diastolic deceleration area”) can be used (Error! Reference source not found.).
The diastolic deceleration area can be quantified with the following trapezoid area formula:
A = V2 (a + b) h where A is area; “a ” and “b ” are the bases of the trapezoid; “h ” is height.
This formula needs to be customized, using the variables from Error! Reference source not found.:
DDA = /2 (DN + D) At where DDA is diastolic deceleration area; DN is dicrotic notch (measured as velocity — m/s); D is end diastolic velocity (measured as velocity - m/s); At = t2 - tl (measured as DT- deceleration time).
Use of the invention
As demonstrated in Figure 3, the introduction of dicrotic notching to Doppler indices allows for a clear distinction between systole and diastole. This, in turn, is an important prerequisite for the implementation of new measurement modalities, not only applicable to the diastole, but to systole as well.
This new approach has several important implications:
- it delivers unprecedented precision in the evaluation of vasodilatation and therefore - fetal brain sparing effect;
- area under the Doppler curve quantification provides means for earlier diagnosis of fetal hypoxemia/hypoxia and anaemia, growth restriction, as well as broader spectrum of diagnostic possibilities in twin-to-twin transfusion syndrome and other conditions;
- calculation of systolic and diastolic areas in Pulse wave Doppler is applicable in all areas of human and veterinary medicine.
References: Mone F., McAuliffe FM, Ong S. The clinical application of Doppler ultrasound in obstetrics. The Obstetrician and Gynaecologist 2015;17:13-19. F.C. Battaglia et al. A practical classification of newborn infants by weight and gestational age. J Pediatr. 1967. Gosling RG, King DH, Newman DL and Woodcock JP. Transcutaneous measurement of arterial blood velocity ultrasound. Ultrasonics for Industry Conference Papers (Guildford: IPC) 1969; 16-32. Lees, C. C., Stampalija, T., Baschat, A. et al. ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound in Obstetrics and Gynecology (Vol. 56, Issue 2, pp. 298-312) 2020. https://doi.org/10.1002/uog.22134 Wladimiroff JW, Tonge HM, Stewart PA. Doppler ultrasound assessment of cerebral blood flow in the human fetus. Br J Obstet Gynaecol 1986; 93: 471—475 Cohen E, Baerts W, van Bel F. Brain-Sparing in Intrauterine Growth Restriction: Considerations for the Neonatologist. Neonatology 2015;108:269-276. doi: 10.1159/000438451 Baschat AA, Gembruch U. The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol. 2003 Feb;21(2): 124-7. doi: 10.1002/uog.20. PMID: 12601831. DeVore GR. The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses. Am J Obstet Gynecol. 2015 Jul;213(l):5-15. doi: 10.1016/j.ajog.2015.05.024. PMID: 26113227. C. C., Stampalija, T., Baschat, A., da Silva Costa, F., Ferrazzi, E., Figueras, F., Hecher,
K., Poon, L. C., Salomon, L. J., Unterscheider, J. (2020). ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. In Ultrasound in Obstetrics and Gynecology (Vol. 56, Issue 2, pp. 298-312). John Wiley and Sons Ltd. https://doi.org/ 10.1002/uog.22134 Vollgraff Heidweiller-Schreurs, C. A., de Boer, M. A., Heymans, M. W., Schoonmade,
L. J., Bossuyt, P. M. M., Mol, B. W. J., de Groot, C. J. M. Bax, C. J. (2018). Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis. In Ultrasound in Obstetrics and Gynecology (Vol. 51, Issue 3, pp. 313-322). John Wiley and Sons Ltd. https://doi.org/10.1002/uog.18809 11. Dunn L, Sherrell H, Kumar S. Review: Systematic review of the utility of the fetal CPR measured at term for the prediction of adverse perinatal outcome. Placenta. 2017; 54: 68-75.
12. Meher S, Hernandez- Andrade E, Basheer SN, Lees C. Impact of cerebral redistribution
5 on neurodevelopmental outcome in small-for-gestational-age or growth-restricted babies: a systematic review. Ultrasound Obstet Gynecol 2015; 46: 398-404.
13. Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W. Consensus definition for placental fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 2016; 48(3): 833-9.
1014. G. Dahlgren, F. Veintemilla, G. Settergren, J. Liska, Left ventricular end- systolicpressure estimated from measurements in a peripheral artery, J. Cardiothorac.Vasc. Anesth. 5 (6) (1991) 551-553.
15. H.L. Falsetti, R.E. Mates, R.J. Carroll, R.L. Gupta, A.C. Bell, Analysis and correction of pressure wave distortion influid-filled catheter systems, Circulation 49(1) (1974)
15 165-172.
16. A.C. Guyton, J.E. Hall, Textbook of Medical Physiology, 11th edition, Elsevier Inc, Philadelphia , PA (2006), p. pl 09.
17. J.L. Hebert, Y. Lecarpentier, K. Zamani, C. Coirault, G. Daccache, D. Chemla,N. Wuilliez, L. Larsonneur, Relation between aortic dicrotic notch pressure andmean
20 aortic pressure in adults, Am. J. Cardiol. 76 (4) (1995) 301-306.
18. Politi, M. T., Ghigo, A., Fernandez, J. M., Khelifa, I., Gaudric, J., Fullana, J. M., Lagree, P. Y. (2016). The dicrotic notch analyzed by a numerical model. Computers in Biology and Medicine, 54—64. https://doi.org/ 10.1016/j .compbiomed.2016.03.005
19. Gamrah, M. A., Xu, J., el Sawy, A., Aguib, H., Yacoub, M., Parker, K. H. (2020).
25 Mechanics of the dicrotic notch: An acceleration hypothesis. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, 1253— 1259. https://doi.org/10.! 177/0954411920921628

Claims

1. Method for evaluation of the blood flow, including step of measurement the curve of wave waveforms (or other Doppler modalities), derived from Doppler velocimetry of blood vessels (arteries or veins), characterized in measurement of areas under the said curve of Pulse wave waveforms (or other Doppler modalities).
2. Method according to claim 1, characterized in that the area is a systolic area in Pulse wave waveforms (or other Doppler modalities), defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels.
3. Method according to claim 1, characterized in that the area is a diastolic area in Pulse wave waveforms (or other Doppler modalities), defined by the presence of dicrotic notch in Doppler velocimetry of blood vessels;
PCT/BG2022/050004 2022-08-05 2022-08-05 Method for quantification of doppler velocimetry in blood vessels Ceased WO2024026542A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP22772404.4A EP4565128A1 (en) 2022-08-05 2022-08-05 Method for quantification of doppler velocimetry in blood vessels
PCT/BG2022/050004 WO2024026542A1 (en) 2022-08-05 2022-08-05 Method for quantification of doppler velocimetry in blood vessels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BG2022/050004 WO2024026542A1 (en) 2022-08-05 2022-08-05 Method for quantification of doppler velocimetry in blood vessels

Publications (1)

Publication Number Publication Date
WO2024026542A1 true WO2024026542A1 (en) 2024-02-08

Family

ID=83355119

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BG2022/050004 Ceased WO2024026542A1 (en) 2022-08-05 2022-08-05 Method for quantification of doppler velocimetry in blood vessels

Country Status (2)

Country Link
EP (1) EP4565128A1 (en)
WO (1) WO2024026542A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140350405A1 (en) * 2011-11-30 2014-11-27 Koninklijke Philips N.V. System and method for identifying high risk pregnancies
US20180296104A1 (en) * 2017-04-13 2018-10-18 Atcor Medical Pty Ltd Non-invasive blood pressure measurement
US20200090819A1 (en) * 2018-09-14 2020-03-19 Fundacio Institut De Ciencies Fotoniques System and computer-implemented method for detecting and categorizing pathologies through an analysis of pulsatile blood flow
US20210401332A1 (en) * 2018-11-15 2021-12-30 My-Vitality Sàrl Self-monitoring and care assistant for achieving glycemic goals

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140350405A1 (en) * 2011-11-30 2014-11-27 Koninklijke Philips N.V. System and method for identifying high risk pregnancies
US20180296104A1 (en) * 2017-04-13 2018-10-18 Atcor Medical Pty Ltd Non-invasive blood pressure measurement
US20200090819A1 (en) * 2018-09-14 2020-03-19 Fundacio Institut De Ciencies Fotoniques System and computer-implemented method for detecting and categorizing pathologies through an analysis of pulsatile blood flow
US20210401332A1 (en) * 2018-11-15 2021-12-30 My-Vitality Sàrl Self-monitoring and care assistant for achieving glycemic goals

Non-Patent Citations (19)

* Cited by examiner, † Cited by third party
Title
A.C. GUYTONJ.E. HALL: "Textbook of Medical Physiology", 2006, ELSEVIER INC, pages: 9
BASCHAT AA, GEMBRUCH U: " The cerebroplacental Doppler ratio revisited. Ultrasound", OBSTET GYNECOL, vol. 21, no. 2, February 2003 (2003-02-01), pages 124 - 7
C. C., STAMPALIJA, T., BASCHAT, A., DA SILVA COSTA, F., FERRAZZI, E., FIGUERAS, F., HECHER,K., POON, L. C., SALOMON, L. J., UNTERS: " ISUOG Practice Guidelines:diagnosis and management of small-for-gestational-age fetus and fetal growth restriction", ULTRASOUND IN OBSTETRICS AND GYNECOLOGY, vol. 56, 2020, pages 298 - 312
COHEN E, BAERTS W, VAN BEL F.: "Brain-Sparing in Intrauterine Growth Restriction:Considerations for the Neonatologist", NEONATOLOGY, vol. 108, 2015, pages 269 - 276
DEVORE GR: "The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses", AM J OBSTET GYNECOL, vol. 213, no. l, July 2015 (2015-07-01), pages 5 - 15
DUNN LSHERRELL HKUMAR S: "Review: Systematic review of the utility of the fetal CPR measured at term for the prediction of adverse perinatal outcome", PLACENTA, vol. 54, 2017, pages 68 - 75, XP085039645, DOI: 10.1016/j.placenta.2017.02.006
F.C. BATTAGLIA ET AL.: "A practical classification of newborn infants by weight and gestational", J PEDIATR, 1967
G. DAHLGREN, F. VEINTEMILLA, G. SETTERGREN, J. LISKA: " Left ventricular end-systolicpressure estimated from measurements in a peripheral artery", CARDIOTHORAC.VASC. ANESTH, vol. 5, no. 6, 1991, pages 551 - 553
GAMRAH, M. AXU, JEL SAWY, AAGUIB, HYACOUB, MPARKER, K. H: "Mechanics of the dicrotic notch: An acceleration hypothesis. Proceedings of the Institution of Mechanical Engineers, Part H", JOURNAL OF ENGINEERING IN MEDICINE, 2020, pages 1253 - 1259, Retrieved from the Internet <URL:https://doi.org/10.!177/0954411920921628>
GORDIJN SJBEUNE IMTHILAGANATHAN BPAPAGEORGHIOU ABASCHAT AABAKER PNSILVER RMWYNIA KGANZEVOORT W: "Consensus definition for placental fetal growth restriction: a Delphi procedure", ULTRASOUND OBSTET GYNECOL, vol. 48, no. 3, 2016, pages 833 - 9
GOSLING RGKING DHNEWMAN DLWOODCOCK JP: "Transcutaneous measurement of arterial blood velocity ultrasound", ULTRASONICS FOR INDUSTRY CONFERENCE PAPERS (GUILDFORD: IPC, 1969, pages 16 - 32
H.L. FALSETTIR.E. MATESR.J. CARROLLR.L. GUPTAA.C. BELL: "Analysis and correction of pressure wave distortion influid-filled catheter systems", CIRCULATION, vol. 49, no. 1, 1974, pages 165 - 172, XP055278646, DOI: 10.1161/01.CIR.49.1.165
J.L. HEBERTY. LECARPENTIERK. ZAMANIC. COIRAULTG. DACCACHED. CHEMLAN. WUILLIEZL. LARSONNEUR: "Relation between aortic dicrotic notch pressure andmean aortic pressure in adults", AM. J. CARDIOL, vol. 76, no. 4, 1995, pages 301 - 306, XP005497327, DOI: 10.1016/S0002-9149(99)80086-1
LEES, C. CSTAMPALIJA, TBASCHAT, A ET AL.: "ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction", ULTRASOUND IN OBSTETRICS AND GYNECOLOGY, vol. 56, 2020, pages 298 - 312, Retrieved from the Internet <URL:hgps:Hdoi.orp-/l0.1002/uog.22134>
MEHER SHERNANDEZ-ANDRADE EBASHEER SNLEES C: "Impact of cerebral redistribution on neurodevelopmental outcome in small-for-gestational-age or growth-restricted babies: a systematic review", ULTRASOUND OBSTET GYNECOL, vol. 46, 2015, pages 398 - 404
MONE FMCAULIFFE FMONG S: "The clinical application of Doppler ultrasound in obstetrics", THE OBSTETRICIAN AND GYNAECOLOGIST, vol. 17, 2015, pages 13 - 19
POLITI, M. T., GHIGO, A., FERNANDEZ, J. M., KHELIFA, I., GAUDRIC, J., FULLANA, J. M., LAGREE, P. Y: "The dicrotic notch analyzed by a numerical model. Computers in", BIOLOGY AND MEDICINE, 2016, pages 54 - 64, XP029511345, Retrieved from the Internet <URL:https://d0i.0rg/l0.1016/j.compbiomed.2016.03.005> DOI: 10.1016/j.compbiomed.2016.03.005
VOLLGRAFF HEIDWEILLER-SCHREURS, C. ADE BOER, M. AHEYMANS, M. WSCHOONMADE, L. JBOSSUYT, P. M. MMOL, B. W. J.DE GROOT, C. J. MBAX, C: "Ultrasound in Obstetrics and Gynecology", vol. 51, 2018, JOHN WILEY AND SONS LTD, article "Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis", pages: 313 - 322
WLADIMIROFF JWTONGE HMSTEWART PA: "Doppler ultrasound assessment of cerebral blood flow in the human fetus", BR J OBSTET GYNAECOL, vol. 93, 1986, pages 471 - 475

Also Published As

Publication number Publication date
EP4565128A1 (en) 2025-06-11

Similar Documents

Publication Publication Date Title
Mari et al. Intrauterine growth restriction: how to manage and when to deliver
CN106682442B (en) Cerebral apoplexy early warning and cerebrovascular health management system
Wright et al. Cerebral blood flow velocity in term newborn infants: changes associated with ductal flow
Nori et al. Radiological modalities for the assessment of fetal growth restriction: a comprehensive review
Wang et al. [Retracted] Value of Ultrasonic Image Features in Diagnosis of Perinatal Outcomes of Severe Preeclampsia on account of Deep Learning Algorithm
Colan et al. Use of the indirect axillary pulse tracing for noninvasive determination of ejection time, upstroke time, and left ventricular wall stress throughout ejection in infants and young children
WO2024026542A1 (en) Method for quantification of doppler velocimetry in blood vessels
Wan et al. A pilot study of pulse contour cardiac output monitoring in patients with septic shock
RU2402271C1 (en) Diagnostic technique for fetoplacental insufficiency
Gudmundsson Importance of venous flow assessment for clinical decision-making
Hashemi Attar et al. Fetal myocardial performance index in pregnancies with idiopathic mildly increased amniotic fluid volume
Kim et al. Transcranial doppler arterial pressure gradient is associated with delayed infarction after subarachnoid hemorrhage
Ma et al. [Retracted] Prenatal Prediction of Fetal Growth Restriction and Postnatal Outcomes by Ultrasound Assessment of Fetal Myocardial Performance Index and Blood Flow Spectrum
Ackerman-Banks et al. Continuous non-invasive hemodynamic monitoring in early onset severe preeclampsia
RU2557904C1 (en) Diagnostic technique for chronic foetal hypoxia
Lakhno et al. Fetal autonomic malfunction as a marker of fetal distress in growth-restricted fetuses: three case reports
Su et al. Ultrasound probe pressure but not maternal Valsalva maneuver alters Doppler parameters during fetal middle cerebral artery Doppler ultrasonography
Zheng et al. Diagnostic efficiency of ultrasound diagnosis of venous catheters and venous catheter blood flow spectrum
Gomes et al. Waveform Morphology Comparison in Wearable Blood Pressure Sensors
Ignatov et al. Diastolic deceleration area in the fetal MCA: a new Doppler parameter
RU2372026C2 (en) Noninvasive diagnostic technque for coronary atherosclerosis
CN116919468B (en) Peripheral blood vessel tension measuring method and device based on ultrasound
Asir et al. The effect of coronavirus infection (COVID19) on fetomaternal blood flow at term
RU2735926C1 (en) Method for assessing fetal health in pregnancy
RU2204313C2 (en) Method for predicting gestosis occurrence in pregnant women suffering from pyelonephritis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22772404

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2022772404

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2022772404

Country of ref document: EP

Effective date: 20250305

WWP Wipo information: published in national office

Ref document number: 2022772404

Country of ref document: EP